Fowl Cholera

Fowl cholera is a highly contagious and economically devastating bacterial disease of domestic and wild birds, caused by the Gram-negative bacterium Pasteurella multocida. It manifests in peracute, acute, and chronic forms, with acute septicemia and sudden death being the most common presentations in chickens and turkeys. The disease affects all poultry sectors, including commercial broilers, layers, broiler breeders, turkeys, ducks, and backyard flocks, leading to significant mortality, decreased egg production, and increased culling. In commercial layers and breeders, mortality can reach 50% or more, while in broilers, the disease is less common but can cause severe losses when it occurs. The global poultry industry faces substantial economic losses due to fowl cholera, particularly in regions with intensive production and poor biosecurity. The disease is also a significant concern in waterfowl, where it can cause large-scale die-offs. The etiological agent, Pasteurella multocida, is a small, non-motile, encapsulated coccobacillus that exhibits a wide range of serotypes based on capsular and somatic antigens. The disease is often secondary to stress factors such as poor ventilation, overcrowding, and concurrent infections, which compromise the bird's immune system and facilitate bacterial invasion.

The primary causative agent of fowl cholera is Pasteurella multocida, a Gram-negative, non-spore-forming, facultatively anaerobic coccobacillus. It is classified into five capsular serogroups (A, B, D, E, F) and 16 somatic serotypes (1-16) based on the lipopolysaccharide antigens. In poultry, serotypes 1, 3, and 4 are most commonly associated with fowl cholera, with serotype 1 being predominant in North America. The bacterium possesses several virulence factors, including a polysaccharide capsule that resists phagocytosis, fimbriae and adhesins for attachment to host cells, and an endotoxin (lipopolysaccharide) that triggers a severe inflammatory response leading to septic shock. Additionally, Pasteurella multocida produces outer membrane proteins and iron acquisition systems that enhance its survival in the host. The bacterium is susceptible to common disinfectants and dies quickly in the environment, but it can persist in carcasses, feces, and contaminated water for weeks. Transmission occurs horizontally through direct contact with infected birds, ingestion of contaminated feed or water, and inhalation of aerosolized bacteria. Wild birds, rodents, and other animals can serve as mechanical vectors. The organism can also be carried asymptomatically by recovered birds, which become carriers and shed the bacterium intermittently, perpetuating the disease within a flock.

Fowl cholera occurs worldwide and affects a wide range of avian species, with turkeys being highly susceptible, followed by chickens, ducks, and geese. In commercial poultry, the disease is more common in adult layers and breeders, particularly during peak egg production, due to the stress of high production and associated metabolic demands. Broilers are less commonly affected, but outbreaks can occur in flocks with poor management. The disease is often sporadic, with outbreaks occurring when susceptible birds are exposed to the bacterium, often introduced by carrier birds or contaminated equipment. Morbidity can range from 10% to 100%, and mortality from 10% to 50% or higher in untreated flocks. In layers, egg production may drop by 20% to 50%, and in breeders, fertility and hatchability may be adversely affected. The disease is more prevalent in warm, humid climates and during the summer months, but it can occur year-round. Poor biosecurity, high stocking density, inadequate ventilation, and concurrent infections (e.g., mycoplasmosis, infectious bronchitis) are significant risk factors. Wild birds, particularly waterfowl, can serve as reservoirs and introduce the bacterium to domestic flocks. The disease is often endemic in areas with free-range or backyard poultry, where biosecurity is minimal. In integrated poultry operations, the disease can spread rapidly between houses on the same farm, leading to significant economic losses.

The pathogenesis of fowl cholera begins with the entry of Pasteurella multocida into the host through the respiratory tract, oral cavity, or conjunctiva. The bacterium colonizes the upper respiratory tract and tonsils, where it multiplies and invades the bloodstream, leading to a rapid bacteremia. The capsule and endotoxin are critical for virulence, as they protect the bacterium from phagocytosis and trigger a massive release of pro-inflammatory cytokines, such as tumor necrosis factor-alpha and interleukins, resulting in systemic inflammatory response syndrome (SIRS). This leads to increased vascular permeability, vasodilation, and disseminated intravascular coagulation (DIC), causing widespread petechial and ecchymotic hemorrhages in multiple organs, including the heart, liver, spleen, and lungs. The liver and spleen become enlarged and congested, and focal necrosis may develop. In peracute cases, death occurs within hours due to septic shock before significant lesions develop. In acute cases, the bird may survive for 24-48 hours, allowing the development of fibrinous pericarditis, perihepatitis, and airsacculitis. Chronic infections may result in localized lesions, such as arthritis, synovitis, and cellulitis of the wattles and comb, due to the persistence of the bacterium in joints and tissues. The immune response is primarily humoral, with antibodies against the capsule and outer membrane proteins providing some protection, but the disease can still occur in vaccinated flocks if the challenge is high or the vaccine serotype does not match the field strain.

Several intrinsic and extrinsic factors predispose poultry to fowl cholera. Intrinsic factors include age, with adult birds being more susceptible than young chicks, and genetic susceptibility, as some breeds and lines are more resistant than others. High production stress, such as peak egg production in layers and breeders, increases susceptibility due to immunosuppression. Concurrent infections, such as infectious bronchitis, mycoplasmosis, and immunosuppressive diseases like infectious bursal disease and Marek's disease, can compromise the immune system and increase the risk of fowl cholera. Extrinsic factors include poor biosecurity, which allows the introduction of the bacterium through contaminated equipment, vehicles, or personnel. High stocking density and poor ventilation lead to ammonia accumulation and respiratory irritation, facilitating bacterial invasion. Wet litter and poor sanitation provide a favorable environment for bacterial survival. Nutritional deficiencies, particularly of vitamins A, E, and selenium, can impair the immune response. Stress from handling, transportation, and sudden changes in feed or environment can also precipitate outbreaks. Vaccination failures, due to improper administration, incorrect serotype coverage, or immunosuppression, can leave flocks vulnerable. Additionally, the presence of carrier birds, which may show no clinical signs but shed the bacterium, is a major source of infection for susceptible flocks.

Clinical signs of fowl cholera vary depending on the peracute, acute, or chronic form of the disease. In peracute cases, birds are often found dead without any prior clinical signs, with mortality occurring within hours of exposure. In acute cases, affected birds exhibit depression, anorexia, ruffled feathers, and reluctance to move. They may have a fever, increased thirst, and mucoid discharge from the mouth and nostrils. Respiratory signs include dyspnea, rales, and coughing due to pneumonia and airsacculitis. Cyanosis of the comb and wattles is a classic sign, resulting from septicemia and vascular damage. Diarrhea is common, with feces ranging from watery to bloody, and may be yellowish or greenish. Egg production drops sharply in layers, and shell quality may deteriorate. In chronic cases, birds may develop localized infections, such as swollen wattles (due to cellulitis), arthritis and synovitis (leading to lameness), and torticollis (due to meningitis or otitis media). The chronic form is more common in flocks with some immunity or in the later stages of an outbreak. Mortality can be high, especially in turkeys, and morbidity can reach 100% in susceptible flocks. The clinical signs are not pathognomonic and can be confused with other septicemic diseases, such as avian influenza and Newcastle disease, necessitating laboratory confirmation.

Differential diagnoses for fowl cholera include several other bacterial, viral, and parasitic diseases that present with similar clinical signs and lesions. Avian influenza (AI) and Newcastle disease (ND) are viral diseases that cause sudden death, respiratory signs, and hemorrhagic lesions, but they also cause neurological signs and have characteristic gross lesions such as hemorrhagic proventriculitis and tracheitis. Highly pathogenic AI (HPAI) causes cyanosis of the comb and wattles, similar to fowl cholera, but also causes edema of the head and neck, and is a reportable disease. Fowl typhoid and pullorum disease, caused by Salmonella Gallinarum and Pullorum, respectively, cause septicemia and liver necrosis, but they are more common in young birds and have characteristic lesions such as bronze-colored liver and white nodules in the spleen. Colibacillosis, caused by Escherichia coli, can cause similar respiratory and systemic signs, but it is often secondary to viral infections and is characterized by fibrinous perihepatitis and pericarditis. Erysipelas, caused by Erysipelothrix rhusiopathiae, causes septicemia and skin lesions, but it is more common in turkeys and has a characteristic diamond-shaped skin lesion. Mycoplasmosis, particularly Mycoplasma gallisepticum, causes respiratory signs and airsacculitis, but it is more chronic and has a lower mortality. Coccidiosis, caused by Eimeria species, causes diarrhea and intestinal lesions, but it is more common in young birds and is characterized by intestinal hemorrhage and cecal cores. A definitive diagnosis is made by bacterial isolation and identification of Pasteurella multocida from blood, liver, or bone marrow, and by PCR or serotyping.

The diagnostic algorithm for fowl cholera begins with a thorough flock history, including vaccination status, recent stress events, and mortality patterns. Clinical signs, such as sudden death, depression, and cyanosis, raise suspicion. A complete necropsy of several affected birds is essential. Gross lesions, including petechial hemorrhages on the heart, liver, and spleen, and fibrinous exudates in the pericardium and air sacs, are suggestive. Swabs from the liver, spleen, and bone marrow are collected for bacterial culture on blood agar or MacConkey agar. Pasteurella multocida grows as small, grayish colonies that are oxidase and catalase positive. Biochemical tests, such as indole production and sugar fermentation, confirm the identification. Serotyping is performed using capsular and somatic antigen typing to determine the vaccine strain. Molecular methods, such as PCR, can detect Pasteurella multocida DNA directly from tissues, providing rapid confirmation. Histopathology of the liver, spleen, and lungs shows characteristic lesions, including necrosis and heterophilic infiltration. Serology, such as ELISA, can detect antibodies in recovered flocks, but it is not useful for acute diagnosis. The diagnostic algorithm should also include testing for other pathogens, such as avian influenza and Newcastle disease, to rule out reportable diseases. A definitive diagnosis is crucial for implementing appropriate treatment and control measures.

Laboratory findings in fowl cholera include isolation of Pasteurella multocida from blood, liver, spleen, or bone marrow on blood agar, with characteristic colony morphology and biochemical reactions. The bacterium is Gram-negative, bipolar staining, and non-motile. Serotyping is performed using capsular and somatic antigens, with serotypes 1, 3, and 4 commonly involved. Molecular diagnostics, such as PCR, can detect Pasteurella multocida DNA in tissues, providing rapid confirmation. Serology, using ELISA or agglutination tests, can detect antibodies in recovered flocks, but it is not useful for acute diagnosis. Hematology may show leukocytosis with heterophilia and monocytosis. Blood chemistry may reveal elevated liver enzymes, such as aspartate aminotransferase (AST) and lactate dehydrogenase (LDH), due to hepatic necrosis. In chronic cases, joint fluid may be cultured and show the bacterium. Antimicrobial susceptibility testing is recommended to guide treatment, as resistance to commonly used antibiotics is increasing. Histopathology of the liver shows multifocal coagulative necrosis with heterophilic infiltration, and the spleen shows lymphoid depletion and necrosis. The lungs may show fibrinous pneumonia and airsacculitis. These laboratory findings, combined with clinical signs and gross lesions, confirm the diagnosis of fowl cholera.

Imaging modalities are not commonly used in the diagnosis of fowl cholera in poultry, but they can be useful in chronic cases to evaluate joint involvement. Radiography of affected joints may show soft tissue swelling and, in severe cases, osteomyelitis or arthritis. Ultrasonography can be used to assess the extent of fibrinous exudates in the pericardium and air sacs, but it is rarely performed in clinical practice. Gross necropsy photography is essential for documenting lesions, such as petechial hemorrhages on the heart and liver, and fibrinous pericarditis. These images are valuable for educational and diagnostic purposes. In research settings, advanced imaging, such as computed tomography (CT), may be used to study the pathogenesis of the disease, but it is not practical for routine diagnosis. Therefore, imaging plays a limited role in the diagnosis of fowl cholera, and the primary diagnostic methods remain clinical examination, necropsy, and laboratory testing.

Cytology and histopathology are important for confirming fowl cholera and understanding the disease process. Impression smears from the liver, spleen, or blood may show bipolar-staining coccobacilli, characteristic of Pasteurella multocida. Histopathology of the liver reveals multifocal areas of coagulative necrosis with infiltration of heterophils and macrophages. The spleen shows lymphoid depletion, necrosis, and the presence of bacterial colonies. The lungs exhibit fibrinous pneumonia, with edema and heterophilic infiltration. The heart may show epicardial petechial hemorrhages and fibrinous pericarditis. In chronic cases, the joints show fibrinosuppurative arthritis and synovitis, with the presence of bacterial colonies. The wattles may show cellulitis with necrosis and heterophilic infiltration. The meninges may be involved in cases with torticollis, showing fibrinous meningitis. These histopathological findings, combined with bacterial isolation, provide a definitive diagnosis. Special stains, such as Gram stain, can highlight the Gram-negative bacteria in tissues. Immunohistochemistry can be used to specifically detect Pasteurella multocida antigens in formalin-fixed tissues, which is useful in cases where culture is negative due to prior antibiotic treatment.

Treatment of fowl cholera involves the use of antibiotics, supportive care, and management changes. Antibiotics are most effective when administered early in the outbreak, and the choice of antibiotic should be based on antimicrobial susceptibility testing. Commonly used antibiotics include tetracyclines (e.g., oxytetracycline at 400-500 g/ton of feed or 10-20 mg/kg body weight), sulfonamides (e.g., sulfadimethoxine at 0.05% in drinking water), penicillin (e.g., procaine penicillin at 10,000-20,000 IU/kg body weight), and fluoroquinolones (e.g., enrofloxacin at 10 mg/kg body weight, where legal). In many countries, the use of fluoroquinolones in poultry is restricted due to concerns about antimicrobial resistance. Antibiotics are typically administered in drinking water for 3-5 days, and in severe cases, individual bird treatment may be necessary. Supportive care includes providing clean water, electrolytes, and vitamins (e.g., vitamin A, D3, E, and C) to reduce stress and support the immune system. In addition to treatment, biosecurity measures should be enhanced, including cleaning and disinfection of the premises, removal of dead birds, and isolation of affected flocks. Vaccination of in-contact flocks may be considered, but it is not effective in the face of an outbreak. In severe outbreaks, depopulation may be necessary to prevent the spread of the disease. It is important to note that treatment does not eliminate the carrier state, and recovered birds may remain carriers, so long-term control measures are essential.

The prognosis for fowl cholera depends on the form of the disease, the speed of intervention, and the management practices. In peracute cases, mortality is high, and the prognosis is poor, with death occurring within hours. In acute cases, if treatment is initiated early, mortality can be reduced, but the flock may still experience significant losses, and egg production may take several weeks to recover. Chronic cases have a better prognosis, but affected birds may become carriers and serve as a source of infection for the rest of the flock. The overall flock prognosis is guarded, as the disease can recur if biosecurity is not improved and carrier birds are not removed. In commercial layers, egg production may drop by 20-50% and may not return to pre-outbreak levels, leading to long-term economic losses. In broilers, the disease can cause increased mortality and reduced weight gain, affecting feed conversion ratio (FCR). In turkeys, the disease is often more severe, with higher mortality. The prognosis is also influenced by the presence of concurrent infections and the immune status of the flock. With appropriate treatment and management, the flock can recover, but the disease may become endemic in the flock or farm, requiring long-term control measures.

Follow-up after a fowl cholera outbreak is critical to prevent recurrence and ensure flock recovery. The flock should be monitored daily for clinical signs, and any dead birds should be necropsied to confirm the absence of the disease. Serological monitoring, using ELISA, can be performed 2-4 weeks after the outbreak to assess the immune response and identify potential carriers. Antibiotic treatment should be completed as prescribed, and the water and feed lines should be cleaned and disinfected. The environment should be thoroughly cleaned and disinfected, including the removal of litter and manure, and the premises should be left empty for at least 2-3 weeks before restocking. A biosecurity audit should be conducted to identify and correct any deficiencies, such as inadequate fencing, lack of footbaths, and poor rodent control. In flocks with a history of fowl cholera, vaccination should be considered, using a bacterin or live vaccine that matches the serotype involved. The vaccination program should be reviewed and adjusted as needed. In addition, the flock's nutrition and management should be optimized to reduce stress and improve immune function. Regular monitoring for other diseases, such as mycoplasmosis and infectious bronchitis, is also important, as these can predispose to fowl cholera. Long-term follow-up is essential to ensure the disease does not recur.

Clinical pearls for fowl cholera include the importance of performing a thorough necropsy on multiple birds, as peracute cases may show no lesions. The presence of petechial hemorrhages on the heart, liver, and spleen, along with fibrinous pericarditis and perihepatitis, is highly suggestive. Bipolar staining of the bacteria in impression smears is a quick diagnostic clue. In turkeys, the disease can cause sudden death with minimal signs, so a high index of suspicion is necessary. Pitfalls include misdiagnosing fowl cholera as avian influenza or Newcastle disease, which are reportable diseases, so it is essential to rule these out. Another pitfall is treating with antibiotics without performing antimicrobial susceptibility testing, as resistance is common. Additionally, relying solely on vaccination without addressing biosecurity and management issues can lead to vaccine failure. It is also important to remember that recovered birds can become carriers, so they should be culled or isolated to prevent the spread of the disease. Finally, the use of antibiotics in poultry is regulated, and withdrawal times must be observed to avoid residues in meat and eggs.

Current drug protocols for fowl cholera are based on the AAAP and Plumb's Veterinary Drug Handbook. Antibiotics are the mainstay of treatment, and the choice should be based on culture and sensitivity. Common protocols include: Oxytetracycline at 400-500 g/ton of feed for 7-10 days, or 10-20 mg/kg body weight intramuscularly for 3-5 days. Sulfadimethoxine at 0.05% in drinking water for 5-7 days. Procaine penicillin at 10,000-20,000 IU/kg body weight intramuscularly for 3-5 days. Enrofloxacin at 10 mg/kg body weight orally for 3-5 days, but its use is restricted in some countries. Florfenicol at 20-30 mg/kg body weight orally for 3-5 days. Tylosin at 500 g/ton of feed for 7-10 days, but it is less effective against Pasteurella multocida. Supportive therapy includes electrolytes and vitamins, such as vitamin A at 10,000 IU/kg feed, vitamin D3 at 2,000 IU/kg feed, vitamin E at 100 IU/kg feed, and vitamin C at 200 mg/kg feed. These can be administered in water or feed. Vaccination is recommended for prevention, using a killed bacterin or live vaccine, with two doses given 4-6 weeks apart, followed by boosters every 6-12 months. The vaccine should contain the relevant serotypes. Withdrawal times for antibiotics must be observed, and the use of any drug should be in accordance with local regulations.

Evidence-based literature on fowl cholera is extensive, with numerous studies on the pathogenesis, epidemiology, and control of the disease. Key landmark studies include the characterization of Pasteurella multocida serotypes and their virulence factors, such as the capsule and endotoxin. Research has shown that the disease is more severe in turkeys than in chickens, and that stress factors, such as poor ventilation and high stocking density, increase susceptibility. Field trials have demonstrated the efficacy of antibiotics, such as oxytetracycline and sulfonamides, in reducing mortality, but the emergence of antimicrobial resistance is a growing concern. Vaccination studies have shown that bacterins provide good protection against homologous serotypes, but cross-protection is limited, and the development of live vaccines has been explored. The use of molecular diagnostics, such as PCR, has improved the speed and accuracy of diagnosis. Consensus guidelines from the AAAP and WVPA recommend a comprehensive approach to control, including biosecurity, vaccination, and antimicrobial stewardship. Meta-analyses have highlighted the economic impact of fowl cholera on the poultry industry, emphasizing the need for effective prevention and control strategies. Overall, the literature supports the importance of early diagnosis, appropriate treatment, and long-term management to minimize the impact of fowl cholera.